Author:
Kenan Cadirci ,Turkez Hasan,Tozlu Ozlem Ozdemir,Yapca Omer Erkan,Bayrak Muharrem,Emsen Bugrahan,Mardinoglu Adil
Reference39 articles.
1. Abe, K. and Matsuki, N., Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT, Neurosci. Res., 2000, vol. 38, no. 4, pp. 325–329.
2. Al Jobori, H., Daniele, G., Adams, J., Cersosimo, E., Solis-Herrera, C., Triplitt, C., DeFronzo, R.A., and Abdul-Ghani, M., Empagliflozin treatment is associated with improved ß-cell function in type 2 diabetes mellitus, J. Clin. Endocrinol. Metab., 2018, vol. 103, no. 4, pp. 1402–1407. https://doi.org/10.1210/jc.2017-01838
3. Arslan, M.E., Türkez, H., Özdemir, Ö., and Chikha, O., Ameliorative effect of boric acid against nicotine-induced cytotoxicity on cultured human primary alveolar epithelial cells, J. Boron, 2016, vol. 1, no. 2, pp. 104–109.
4. Association, A.D., 8. Pharmacologic approaches to glycemic treatment, Diabetes Care, 2017, vol. 40, suppl. 1, pp. S64–S74. https://doi.org/10.2337/dc17-S011
5. Bahuguna, A., Khan, I., Bajpai, V.K., and Kang, S.C., MTT assay to evaluate the cytotoxic potential of a drug, Bangladesh J. Pharmacol., 2017, vol. 12, no. 2, pp. 115–118. https://doi.org/10.3329/bjp.v12i2.30892